Shares of Quest Diagnostics Inc. DGX slid 1.71% to $172.01 Wednesday, on what proved to be an all-around positive trading ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Here’s what Tarrant County health officials are telling schools, child care centers and parents about how to prepare for a ...

Fintel reports that on March 4, 2025, Citigroup downgraded their outlook for Quest Diagnostics (NYSE:DGX) from Buy to Neutral ...

DGX outperforms the industry and the S&P 500 composite's gain in the past year, driven by strong core performance and contributions from acquisitions.

Citi downgraded Quest Diagnostics (DGX) to Neutral from Buy with an unchanged price target of $185. The firm believes Quest is well positioned ...

Shares of Quest Diagnostics Inc. DGX shed 1.10% to $175.01 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 1.22% to 5,778.15 ...

Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.

Quest Diagnostics DGX has achieved impressive growth over the past year, with its shares rising 38%. It has outperformed the industry’s 7.7% rise and the S&P 500 composite’s 17.1% gain.

Atria Wealth Solutions Inc. raised its holdings in Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form 13F ...